Skip to article
Astra

Medical Toxicology

Benzodiazepine Toxicity

Manage benzodiazepine toxicity by prioritizing airway and ventilation, actively identifying opioid, alcohol, and proconvulsant co-ingestion, and reserving flumazenil for exceptional pure exposures without seizure risk or benzodiazepine dependence.

Clinical question: How should clinicians stabilize benzodiazepine toxicity and determine whether flumazenil is appropriate?

First priorities

Stabilize ventilation before diagnosing a pure benzodiazepine exposure

Treat physiologic failure, not the drug screen or presumed ingestion alone.

Immediately assess airway patency, respiratory effort, oxygenation, ventilation, mental status, blood pressure, and cardiac rhythm. Establish intravenous access and provide airway management, assisted ventilation, and cardiovascular support when hypoventilation, airway obstruction, apnea, or hemodynamic compromise is present. Pulse oximetry and continuous vital-sign monitoring are specifically emphasized when sedative-related respiratory compromise is possible. dailymed nlm nihFLUMAZENIL INJECTION, USPaccessdata fda[PDF] center for drug evaluation and research - accessdata.fda.gov

Do not use flumazenil as a substitute for definitive airway and ventilatory management. The drug reverses benzodiazepine-mediated effects but does not reverse toxicity from other concomitant medications; an initially somnolent patient may also become agitated and attempt to remove an endotracheal tube or intravenous lines after awakening. dailymed nlm nihFLUMAZENIL INJECTION, USPaccessdata fda[PDF] center for drug evaluation and research - accessdata.fda.gov

A benzodiazepine-predominant presentation may produce marked central nervous system depression with relatively preserved resting heart rate, blood pressure, and respiratory rate. Bradycardia, hypotension, or respiratory depression should increase concern for ethanol, barbiturate, opioid, or other co-exposure rather than reassuring clinicians that the exposure is isolated. BMJToxidromes and a general approach to poisoning

Initial management priorities in suspected benzodiazepine toxicity. dailymed nlm nihFLUMAZENIL INJECTION, USPaccessdata fda[PDF] center for drug evaluation and research - accessdata.fda.govBMJToxidromes and a general approach to poisoning
Clinical findingInterpretationImmediate action
Hypoventilation, airway obstruction, or apneaTime-critical respiratory failure; may reflect benzodiazepines plus opioids or other sedatives. accessdata fda[PDF] center for drug evaluation and research - accessdata.fda.govBMJBenzodiazepine overdose - Symptoms, diagnosis and treatment | BMJ Best Practice USSecure airway and provide assisted ventilation; continue pulse oximetry and vital-sign monitoring. dailymed nlm nihFLUMAZENIL INJECTION, USPaccessdata fda[PDF] center for drug evaluation and research - accessdata.fda.gov
Profound sedation with otherwise relatively normal vital signsCompatible with a GABAergic sedative-hypnotic toxidrome, including benzodiazepines or Z-drugs. BMJToxidromes and a general approach to poisoningContinue observation and supportive management while assessing exposure history and competing causes of coma. BMJToxidromes and a general approach to poisoning
Hypotension despite initial assessmentMay indicate severe poisoning or a non-benzodiazepine co-ingestant. BMJToxidromes and a general approach to poisoningGive intravenous fluid bolus; use norepinephrine if hypotension is fluid-resistant. BMJToxidromes and a general approach to poisoning
Abrupt awakening after antagonistAgitation and attempts to remove lines or airway devices may occur. dailymed nlm nihFLUMAZENIL INJECTION, USPMaintain secure airway access and close bedside supervision during recovery. dailymed nlm nihFLUMAZENIL INJECTION, USP

Risk stratification

Identify the co-ingestion and seizure-risk branches before considering reversal

Flumazenil eligibility depends more on the exposure context than on sedation severity alone.

Determine whether the presentation is plausibly a pure benzodiazepine exposure or a mixed overdose. Death from benzodiazepine overdose is uncommon in isolation; fatal respiratory depression more often involves another respiratory depressant, particularly alcohol or opioids. A history of intentional ingestion should be treated as a major reason to suspect unrecognized co-exposures and to avoid empiric flumazenil. BMJBenzodiazepine overdose - Symptoms, diagnosis and treatment | BMJ Best Practice USBMJBenzodiazepine overdose - Management recommendations | BMJ Best Practice

Specifically identify chronic benzodiazepine use, a seizure disorder, and possible cyclic antidepressant overdose before reversal. Flumazenil can precipitate benzodiazepine withdrawal in tolerant patients and seizures in susceptible patients; FDA labeling highlights seizure risk in long-term benzodiazepine users and cyclic antidepressant overdose. accessdata fda[PDF] center for drug evaluation and research - accessdata.fda.govBMJToxidromes and a general approach to poisoning

Do not use a urine benzodiazepine screen to decide whether a sedated patient should receive flumazenil. Immunoassays are screening tests that yield presumptive positives, whereas confirmation is performed with gas chromatography-mass spectrometry or liquid chromatography-mass spectrometry. Testing can document exposure when clinically or forensically relevant, but airway and ventilation decisions remain clinical. ScienceDirectClorazepate - an overview | ScienceDirect TopicsScienceDirectBromazepam - an overview | ScienceDirect TopicsScienceDirect7 Aminoflunitrazepam - an overview | ScienceDirect Topics

Features that shift management away from flumazenil. accessdata fda[PDF] center for drug evaluation and research - accessdata.fda.govBMJBenzodiazepine overdose - Symptoms, diagnosis and treatment | BMJ Best Practice USBMJToxidromes and a general approach to poisoningBMJBenzodiazepine overdose - Management recommendations | BMJ Best Practice
FindingWhy it mattersManagement implication
Known chronic benzodiazepine exposureAntagonism can precipitate withdrawal and seizures. accessdata fda[PDF] center for drug evaluation and research - accessdata.fda.govBMJToxidromes and a general approach to poisoningAvoid routine flumazenil; support airway and ventilation as needed. BMJBenzodiazepine overdose - Symptoms, diagnosis and treatment | BMJ Best Practice USBMJToxidromes and a general approach to poisoning
Seizure disorderFlumazenil may precipitate seizure. BMJToxidromes and a general approach to poisoningGenerally avoid flumazenil and manage respiratory compromise supportively. BMJToxidromes and a general approach to poisoning
Possible cyclic antidepressant overdoseFDA labeling identifies a high-risk setting for seizure with flumazenil. accessdata fda[PDF] center for drug evaluation and research - accessdata.fda.govDo not use flumazenil; manage as a mixed overdose. accessdata fda[PDF] center for drug evaluation and research - accessdata.fda.govBMJBenzodiazepine overdose - Symptoms, diagnosis and treatment | BMJ Best Practice US
Alcohol or opioid co-ingestionMixed respiratory depressants drive much of the severe morbidity and mortality. BMJBenzodiazepine overdose - Symptoms, diagnosis and treatment | BMJ Best Practice USBMJBenzodiazepine overdose - Management recommendations | BMJ Best PracticeProvide airway and ventilatory support; do not expect flumazenil to reverse non-benzodiazepine effects. accessdata fda[PDF] center for drug evaluation and research - accessdata.fda.gov
Undifferentiated comaRoutine flumazenil in a coma cocktail is hazardous. AHA JournalsPart 8: Advanced Challenges in Resuscitation | CirculationWolters KluwerFlumazenil, naloxone and the ‘coma cocktail’ : British Journal of Clinical PharmacologyUse targeted assessment and supportive resuscitation rather than empiric reversal. AHA JournalsPart 8: Advanced Challenges in Resuscitation | Circulation

When the presentation is not pure benzodiazepine toxicity

With suspected opioid co-ingestion, benzodiazepine reversal will not address opioid-mediated respiratory depression. Continue respiratory support and direct management toward the co-ingestant syndrome rather than escalating flumazenil solely to normalize consciousness. accessdata fda[PDF] center for drug evaluation and research - accessdata.fda.govBMJBenzodiazepine overdose - Symptoms, diagnosis and treatment | BMJ Best Practice US

With possible cyclic antidepressant co-ingestion, avoid flumazenil because antagonist-associated seizure may unmask or worsen a proconvulsant poisoning. In this setting, supportive critical care and toxicology consultation are safer than pharmacologic benzodiazepine reversal. accessdata fda[PDF] center for drug evaluation and research - accessdata.fda.govBMJBenzodiazepine overdose - Symptoms, diagnosis and treatment | BMJ Best Practice USBMJBenzodiazepine overdose - Management recommendations | BMJ Best Practice

Antidote decision

Reserve flumazenil for carefully selected pure benzodiazepine toxicity

The principal tradeoff is transient arousal versus seizure, withdrawal, and resedation risk.

Flumazenil competitively antagonizes benzodiazepine binding and can reverse benzodiazepine-induced sedation. In acute poisoning, it should be considered only when the exposure is believed to be pure benzodiazepine toxicity, the patient has no contraindications, and the expected benefit outweighs the risks of induced seizures or withdrawal. Expert guidance characterizes this as an uncommon emergency department scenario and recommends specialist input from a clinician trained in acute benzodiazepine overdose management. BMJBenzodiazepine overdose - Symptoms, diagnosis and treatment | BMJ Best Practice USBMJToxidromes and a general approach to poisoningBMJBenzodiazepine overdose - Management recommendations | BMJ Best Practice

The most defensible use case is clinically significant respiratory depression or respiratory arrest from a pure benzodiazepine poisoning in a patient without benzodiazepine tolerance, seizure disorder, suspected proconvulsant co-ingestion, or other contraindication. Even in that circumstance, ensure that the airway is secured as appropriate and that ventilatory support is immediately available before dosing. dailymed nlm nihFLUMAZENIL INJECTION, USPBMJBenzodiazepine overdose - Symptoms, diagnosis and treatment | BMJ Best Practice USBMJToxidromes and a general approach to poisoning

Do not use flumazenil simply to improve a neurologic examination, accelerate discharge, or empirically reverse unexplained altered mental status. Historic resuscitation guidance specifically advises against routine inclusion in a coma cocktail because reversal of benzodiazepine intoxication can be hazardous. AHA JournalsPart 8: Advanced Challenges in Resuscitation | CirculationWolters KluwerFlumazenil, naloxone and the ‘coma cocktail’ : British Journal of Clinical Pharmacology

Flumazenil selection framework for suspected benzodiazepine poisoning. accessdata fda[PDF] center for drug evaluation and research - accessdata.fda.govBMJBenzodiazepine overdose - Symptoms, diagnosis and treatment | BMJ Best Practice USBMJToxidromes and a general approach to poisoningBMJBenzodiazepine overdose - Management recommendations | BMJ Best Practice
Decision branchFeaturesAction
Supportive management preferredTypical emergency department overdose, uncertain history, intentional ingestion, or co-ingestion with alcohol, opioids, or proconvulsant drugs. BMJBenzodiazepine overdose - Symptoms, diagnosis and treatment | BMJ Best Practice USBMJBenzodiazepine overdose - Management recommendations | BMJ Best PracticeManage airway, breathing, circulation, and observation; do not use routine flumazenil. BMJBenzodiazepine overdose - Symptoms, diagnosis and treatment | BMJ Best Practice USBMJBenzodiazepine overdose - Management recommendations | BMJ Best Practice
Flumazenil may be consideredPure benzodiazepine poisoning with clinically important respiratory depression or arrest and no contraindications. BMJBenzodiazepine overdose - Symptoms, diagnosis and treatment | BMJ Best Practice USUse only after airway and intravenous access are established and with close monitoring. dailymed nlm nihFLUMAZENIL INJECTION, USPdailymed nlm nihDailyMed - FLUMAZENIL injection, solutionBMJBenzodiazepine overdose - Symptoms, diagnosis and treatment | BMJ Best Practice US
Flumazenil avoidedBenzodiazepine tolerance, seizure disorder, or cyclic antidepressant overdose. accessdata fda[PDF] center for drug evaluation and research - accessdata.fda.govBMJToxidromes and a general approach to poisoningProvide supportive care and seek toxicology guidance; anticipate seizure-management complexity if inadvertent reversal occurs. dailymed nlm nihFLUMAZENIL INJECTION, USPaccessdata fda[PDF] center for drug evaluation and research - accessdata.fda.gov

When reversal is selected

Administer flumazenil slowly and monitor for resedation and seizures

Titrate to a clinically adequate response rather than abrupt full awakening.

For known or suspected benzodiazepine overdose in adults, administer flumazenil 0.2 mg intravenously over 30 seconds. If the desired level of consciousness is not achieved after waiting 30 seconds, give 0.3 mg IV over 30 seconds. Further 0.5 mg IV doses may be given over 30 seconds at 1-minute intervals, to a cumulative maximum of 3 mg. Do not rush administration; labeling directs gradual awakening after securing airway and intravenous access. dailymed nlm nihFLUMAZENIL INJECTION, USPdailymed nlm nihDailyMed - FLUMAZENIL injection, solution

Monitor continuously for resedation, respiratory depression, and residual benzodiazepine effects after reversal. Because the antagonist may wear off before the sedative effect resolves, monitoring after flumazenil is required; product labeling describes an appropriate observation period of up to 120 minutes after reversal in sedation settings. dailymed nlm nihDailyMed - FLUMAZENIL injection, solutionaccessdata fda[PDF] center for drug evaluation and research - accessdata.fda.gov

Be prepared for seizures after flumazenil. Labeling reports that seizures associated with flumazenil have been managed with benzodiazepines, phenytoin, or barbiturates, but higher-than-usual benzodiazepine doses may be required because receptor antagonism is present. This is a reason to administer flumazenil only where seizure treatment and airway support can be delivered immediately. dailymed nlm nihFLUMAZENIL INJECTION, USPdailymed nlm nihDailyMed - FLUMAZENIL injection, solution

Adult flumazenil dosing and post-dose actions for benzodiazepine overdose. dailymed nlm nihFLUMAZENIL INJECTION, USPdailymed nlm nihDailyMed - FLUMAZENIL injection, solutionaccessdata fda[PDF] center for drug evaluation and research - accessdata.fda.gov
StepDose and timingRequired action
Before dosingNo dose until airway and intravenous access are established. dailymed nlm nihFLUMAZENIL INJECTION, USPdailymed nlm nihDailyMed - FLUMAZENIL injection, solutionEnsure capability for assisted ventilation, seizure management, and continuous monitoring. dailymed nlm nihFLUMAZENIL INJECTION, USPaccessdata fda[PDF] center for drug evaluation and research - accessdata.fda.gov
Initial dose0.2 mg IV over 30 seconds. dailymed nlm nihFLUMAZENIL INJECTION, USPdailymed nlm nihDailyMed - FLUMAZENIL injection, solutionAssess level of consciousness after 30 seconds. dailymed nlm nihFLUMAZENIL INJECTION, USPdailymed nlm nihDailyMed - FLUMAZENIL injection, solution
Second dose0.3 mg IV over 30 seconds if needed after the initial 30-second wait. dailymed nlm nihFLUMAZENIL INJECTION, USPdailymed nlm nihDailyMed - FLUMAZENIL injection, solutionAvoid rapid administration and target gradual awakening. dailymed nlm nihFLUMAZENIL INJECTION, USP
Further titration0.5 mg IV over 30 seconds at 1-minute intervals; maximum cumulative dose 3 mg. dailymed nlm nihFLUMAZENIL INJECTION, USPdailymed nlm nihDailyMed - FLUMAZENIL injection, solutionStop at adequate clinical response or maximum cumulative dose. dailymed nlm nihFLUMAZENIL INJECTION, USPdailymed nlm nihDailyMed - FLUMAZENIL injection, solution
Post-reversal observationMonitor for an appropriate period; up to 120 minutes is described after reversal of sedation. dailymed nlm nihDailyMed - FLUMAZENIL injection, solutionWatch for resedation, respiratory depression, residual sedation, agitation, and seizures. dailymed nlm nihFLUMAZENIL INJECTION, USPdailymed nlm nihDailyMed - FLUMAZENIL injection, solutionaccessdata fda[PDF] center for drug evaluation and research - accessdata.fda.gov

Failure to respond or recurrent sedation

Lack of meaningful response should prompt reassessment for an incorrect diagnosis, mixed ingestion, structural or metabolic causes of depressed consciousness, or respiratory failure that requires ongoing ventilatory support. Do not interpret nonresponse as justification for exceeding the labeled cumulative 3 mg overdose regimen. dailymed nlm nihFLUMAZENIL INJECTION, USPdailymed nlm nihDailyMed - FLUMAZENIL injection, solutionaccessdata fda[PDF] center for drug evaluation and research - accessdata.fda.gov

Resedation after initial reversal requires renewed airway and respiratory assessment rather than automatic repeated antidote treatment. Continuous-infusion flumazenil has been reported for prolonged toxicity, but the cited evidence includes case-level experience rather than a routine emergency department regimen; use requires toxicology or critical care oversight. dailymed nlm nihDailyMed - FLUMAZENIL injection, solutionWileyContinuous‐Infusion Flumazenil in the Management of ...Wolters Kluwer1258 : Critical Care Medicine - Lippincott

Disposition

Observe until respiratory risk and recurrent sedation have resolved

Disposition follows clinical stability and exposure risk, not transient improvement in alertness.

Continue monitored care after significant benzodiazepine toxicity until the patient no longer has respiratory depression, airway vulnerability, or recurrent sedation. Patients treated with flumazenil require observation for resedation and residual benzodiazepine effects because reversal may be shorter-lived than the sedative exposure. dailymed nlm nihDailyMed - FLUMAZENIL injection, solutionaccessdata fda[PDF] center for drug evaluation and research - accessdata.fda.gov

Patients with mixed overdose, persistent cardiorespiratory compromise, seizures, recurrent sedation after reversal, or an uncertain exposure history require escalation to monitored acute care and poison-center or toxicology guidance. In intentional overdose, complete mental health assessment after medical stabilization rather than treating transient arousal as medical clearance. BMJBenzodiazepine overdose - Management recommendations | BMJ Best Practice

For patients with uncomplicated sedative effects managed without flumazenil, the endpoint remains sustained clinical recovery with stable ventilation and vital signs under observation. Do not discharge based solely on a presumptive urine immunoassay result; confirmatory GC-MS or LC-MS testing may establish analyte identity when needed but does not replace clinical assessment. ScienceDirectClorazepate - an overview | ScienceDirect TopicsScienceDirectBromazepam - an overview | ScienceDirect TopicsScienceDirect7 Aminoflunitrazepam - an overview | ScienceDirect Topics

Disposition triggers after benzodiazepine toxicity. dailymed nlm nihDailyMed - FLUMAZENIL injection, solutionaccessdata fda[PDF] center for drug evaluation and research - accessdata.fda.govBMJBenzodiazepine overdose - Management recommendations | BMJ Best Practice
Clinical courseDisposition implication
Persistent or recurrent respiratory depression, airway obstruction, or apneaContinue monitored care with ventilatory support capability. accessdata fda[PDF] center for drug evaluation and research - accessdata.fda.gov
Resedation after flumazenilExtend monitoring and reassess airway, ventilation, and mixed exposure risk. dailymed nlm nihDailyMed - FLUMAZENIL injection, solutionaccessdata fda[PDF] center for drug evaluation and research - accessdata.fda.gov
Seizure after flumazenil or suspected proconvulsant co-ingestionEscalate to acute care with seizure-treatment capability and toxicology input. dailymed nlm nihFLUMAZENIL INJECTION, USPaccessdata fda[PDF] center for drug evaluation and research - accessdata.fda.govBMJBenzodiazepine overdose - Management recommendations | BMJ Best Practice
Intentional overdose after medical stabilizationObtain a full mental health assessment. BMJBenzodiazepine overdose - Management recommendations | BMJ Best Practice

Common questions

Should flumazenil be used for benzodiazepine-associated coma?

No. Routine use in undifferentiated coma is discouraged because flumazenil can precipitate seizures or withdrawal and does not reverse non-benzodiazepine co-ingestants. Use targeted resuscitation and reserve reversal for carefully selected pure exposures. accessdata fda[PDF] center for drug evaluation and research - accessdata.fda.govBMJBenzodiazepine overdose - Symptoms, diagnosis and treatment | BMJ Best Practice USBMJToxidromes and a general approach to poisoningAHA JournalsPart 8: Advanced Challenges in Resuscitation | CirculationWolters KluwerFlumazenil, naloxone and the ‘coma cocktail’ : British Journal of Clinical Pharmacology

What is the maximum adult flumazenil dose for suspected benzodiazepine overdose?

The labeled cumulative maximum is 3 mg IV: 0.2 mg over 30 seconds, then 0.3 mg after 30 seconds if needed, followed by 0.5 mg doses at 1-minute intervals. dailymed nlm nihFLUMAZENIL INJECTION, USPdailymed nlm nihDailyMed - FLUMAZENIL injection, solution

References

  1. FLUMAZENIL INJECTION, USPdailymed.nlm.nih.gov · dailymed.nlm.nih.gov
  2. DailyMed - FLUMAZENIL injection, solutiondailymed.nlm.nih.gov · dailymed.nlm.nih.gov
  3. [PDF] center for drug evaluation and research - accessdata.fda.govwww.accessdata.fda.gov · www.accessdata.fda.gov
  4. Benzodiazepine overdose - Symptoms, diagnosis and treatment | BMJ Best Practice USbestpractice.bmj.com · bestpractice.bmj.com
  5. Toxidromes and a general approach to poisoningadc.bmj.com · adc.bmj.com
  6. Benzodiazepine overdose - Management recommendations | BMJ Best Practicebestpractice.bmj.com · bestpractice.bmj.com
  7. Part 10.2: Toxicology in ECC | Circulationwww.ahajournals.org · www.ahajournals.org
  8. 2023 American Heart Association Focused Update on the ...www.ahajournals.org · www.ahajournals.org
  9. An Update to the American Heart Association Guidelines for ...www.ahajournals.org · www.ahajournals.org
  10. Toxidromes | Nature Reviews Disease Primerswww.nature.com · www.nature.com
  11. Part 8: Advanced Challenges in Resuscitation | Circulationwww.ahajournals.org · www.ahajournals.org
  12. Trends in antidote use in France from 2015 to 2021: a nationwide poison centers study | Scientific Reportswww.nature.com · www.nature.com
  13. Clorazepate - an overview | ScienceDirect Topicswww.sciencedirect.com · www.sciencedirect.com
  14. Loprazolam - an overview | ScienceDirect Topicswww.sciencedirect.com · www.sciencedirect.com
  15. Bromazepam - an overview | ScienceDirect Topicswww.sciencedirect.com · www.sciencedirect.com
  16. 7 Aminoflunitrazepam - an overview | ScienceDirect Topicswww.sciencedirect.com · www.sciencedirect.com
  17. A strategy for the detection of benzodiazepine drugs using low ...analyticalsciencejournals.onlinelibrary.wiley.com · analyticalsciencejournals.onlinelibrary.wiley.com
  18. Development and Validation of an HPLC–MS/MS Method for the ...analyticalsciencejournals.onlinelibrary.wiley.com · analyticalsciencejournals.onlinelibrary.wiley.com
  19. Flumazenil, naloxone and the ‘coma cocktail’ : British Journal of Clinical Pharmacologyjournals.lww.com · journals.lww.com
  20. Continuous‐Infusion Flumazenil in the Management of ...accpjournals.onlinelibrary.wiley.com · accpjournals.onlinelibrary.wiley.com
  21. Adverse Events Associated with Flumazenil Treatment for the ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  22. Schizophrenia and Related Psychoses - Wiley Online Libraryonlinelibrary.wiley.com · onlinelibrary.wiley.com
  23. 1258 : Critical Care Medicine - Lippincottjournals.lww.com · journals.lww.com
  24. Prehospital midazolam use and outcomes among patients with out ...www.neurology.org · www.neurology.org